Support for US HUPO Meeting "Future of Proteomics"

支持美国HUPO会议“蛋白质组学的未来”

• 批准号: 8319942
• 负责人: Karin D Rodland
• 金额: $ 2.3万
• 依托单位: BATTELLE PACIFIC NORTHWEST LABORATORIES
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-03-01 至 2013-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8319942
• 关键词: Address; Affect; Animal Model; Area; Biological; Biological Assay; Biological Markers; Biology; Biosensor; Biotechnology; California; Cardiovascular Diseases; Cell physiology; Clinic; Clinical; Coffee; Collaborations; Communicable Diseases; Complement; Country; Development; Diagnostic; Disabled Persons; Discipline; Disease; Early Diagnosis; Educational Activities; Educational workshop; Experimental Designs; Faculty; Fostering; Funding; Funding Applicant; Future; Goals; Growth; Health; Human; Institutes; Intervention; Laboratories; Learning; Liquid substance; Lung diseases; Mails; Malignant Neoplasms; Mass Spectrum Analysis; Metabolism; Methods; Minority; Minority Groups; Minority-Serving Institution; Mission; Oral; Participant; Persons; Plants; Postdoctoral Fellow; Protein Microchips; Proteins; Proteome; Proteomics; Published Comment; Records; Recruitment Activity; Research; Research Personnel; San Francisco; Scientist; Signal Pathway; Site; Societies; Solutions; Staging; Students; Technology; Thinking; Time; Training; Translations; Underrepresented Minority; United States; Universities; Validation; Woman; abstracting; base; biological systems; career; career development; cell growth regulation; clinical application; density; design; graduate student; handicapping condition; human disease; human tissue; innovation; insight; interest; meetings; member; multidisciplinary; new technology; novel; operation; outcome forecast; posters; professor; prognostic; programs; social; symposium; translational medicine; treatment strategy; trend

DESCRIPTION (provided by applicant): We request partial funding support for operation of the 2012 Annual Meeting of the United States Human Proteome Organization (US-HUPO) entitled "The Future of Proteomics", to be held March 4-7, 2012 in San Francisco, California. Since the first US HUPO meeting in 2005, this venue has been and continues to be a vital conference for the highly interdisciplinary scientific field of proteomics, particularly as directe towards biological and clinical questions. US-HUPO is a unique meeting of scientists because it truly reflects the multidisciplinary interactions that have allowed proteomic researchers to approach and solve sophisticated biomedical problems. The US HUPO meeting endeavors to promote the clinical application and translation of diverse technological platforms including mass spectrometry, protein microarrays, biosensors, clinical assays to biomarker discovery and validation for diagnostic, prognostic and treatment purposes. The conference is heavily attended and has always attracted first-rate speakers in this field. The 2012 Annual Meeting will again bring together an outstanding and diverse group of scientists at the forefront of proteomics. Invited speakers in the symposium will explicitly discuss applications relevant to a wide range of diseases including cardiovascular disease, cancer, and infectious diseases. As technological advances made in the recent years are of critical importance in enabling scientists to more effectively address biological problems, the technological future of proteomics will also be a hallmark of the meeting. The topics chosen will educate participants on the latest, most effective technologies and methods, illustrate successful translation of these technologies into the clinic, and highlight new directions and grand challenges for the future of this field. Panel discussions will be held on key topics in order to encourage a robust dialogue between speakers and meeting participants to discuss critical goals for the future in proteomics, outline anticipated obstacles, and brainstorm solutions. This year US-HUPO will introduce parallel Career Development sessions in Biotechnology and Biological Applications, to provide early stage investigators with crucial insights into growth areas in proteomics and strategies for professional development. The poster sessions will also offer a more informal exchange of scientific ideas and advances. Ample time will be devoted to social venues for attendees to meet each other and establish new contacts and collaborations. Currently, 29% of the invited speakers are either women or members of minority groups. Once the program is completed with selections from submitted abstracts, we expect to have at least 35% women and minority speakers, and at least 35% early stage investigators (assistant professors, post-docs and/ graduate students). Attendance is expected to be 350-450 participants, including 100-150 students/post-docs. Registration is not restricted, and all interested persons may attend. A special effort will be made to recruit minority and industrial participants; the latter should be readily achievable given the concentration of biotechnology firms in the San Francisco Bay area. Participants will present posters on new findings each afternoon. Importantly, the conference provides a forum for young investigators to see the connection between fundamental scientific inquiry and the application of scientific methods to the design of efficacious interventions for human disease. To emphasize this goal, over 20 poster presentations that complement the themes of the meeting will be selected for short oral presentations during the concurrent sessions. Finally, it is important to note that preceding the meeting, US-HUPO offers several Full-Day and Half-Day short courses on contemporary topics in proteomics. PUBLIC HEALTH RELEVANCE (provided by applicant): Funding is requested to support the 2012 Annual Meeting of the United States Human Proteome Organization (US-HUPO), whose mission is to promote scientific and educational activities to encourage the use of new technologies for analyzing proteins in human tissues and fluids, and model organisms, with the ultimate goal of developing critically needed methods for early diagnosis, prognosis of human diseases and new therapies for treating contemporary health problems that affect millions of people worldwide.

描述（由申请人提供）：我们要求为2012年3月4日至7日在加利福尼亚州旧金山举行的题为“蛋白质组学的未来”的2012年人类蛋白质组组织（US-HUPO）的部分资金支持。自2005年美国第一次HUPO会议以来，该场所一直是蛋白质组学的高度跨学科科学领域的重要会议，尤其是直接朝着生物学和临床问题迈进。 US-HUPO是科学家的独特会议，因为它确实反映了允许蛋白质组学研究人员解决并解决复杂的生物医学问题的多学科互动。美国HUPO开展努力，以促进各种技术平台的临床应用和翻译，包括质谱，蛋白质微阵列，生物传感器，生物标志物发现的临床测定以及诊断，预后和治疗目的的验证。会议大量参加，并且一直吸引着该领域的一流演讲者。 2012年的年度会议将再次汇集一群杰出而多样的科学家，处于蛋白质组学的最前沿。研讨会上的受邀演讲者将明确讨论与多种疾病有关的应用，包括心血管疾病，癌症和传染病。随着近年来技术进步在使科学家更有效地解决生物学问题方面至关重要，蛋白质组学的技术未来也将成为会议的标志。所选的主题将教育参与者有关最新，最有效的技术和方法的教育，这说明了这些技术的成功翻译为诊所，并突出了该领域未来的新方向和巨大的挑战。小组讨论将在关键主题上举行，以鼓励演讲者和会议参与者之间进行强有力的对话，以讨论蛋白质组学，概述预期的障碍和头脑风暴解决方案的关键目标。今年，US-HUPO将在生物技术和生物学应用中引入平行的职业发展会议，以使早期舞台调查人员对蛋白质组学和专业策略的增长领域有关键的见解 发展。海报会议还将提供更非正式的科学思想和进步交流。充足的时间将用于社交场所，供与会者见面并建立新的联系和合作。目前，有29％的受邀演讲者是妇女或少数群体的成员。一旦该计划完成了提交摘要的选择，我们预计至少有35％的妇女和少数派发言人，以及至少35％的早期调查人员（助理教授，研究生和/研究生）。出勤率预计为350-450名参与者，包括100-150名学生/毕业后。注册不受限制，所有感兴趣的人都可以参加。将为招募少数民族和工业参与者做出特别的努力；后者应该很容易实现 旧金山湾地区生物技术公司的集中度。参与者每天下午都会在新发现上介绍海报。重要的是，该会议为年轻的研究人员提供了一个论坛，以查看基本科学探究与科学方法在设计人类疾病有效干预措施上的应用之间的联系。为了强调这一目标，将在同时会议期间选择与会议主题相辅相成的20多个海报演示。最后，重要的是要注意，在会议之前，Us-Hupo为当代蛋白质组学的当代主题提供了几门全天和半天的短课程。 公共卫生相关性（由申请人提供）：要求资金支持2012年美国人类蛋白质组组织（US-HUPO）的2012年度会议，其使命是促进科学和教育活动，以鼓励使用新技术来分析人类组织和流体中的蛋白质，并在早期诊断中疾病，以培养人类的最终诊断，并为新的诊断方法进行验证，并具有新的治疗方法，并具有新的治疗方法，并具有新的疾病，并涉及新技术的疾病，并具有新的疾病，并且是对早期诊断的疾病，并有助于新技术，并具有新的治疗方法，并具有新的治疗方法，并具有新的治疗方法，并有助于培训人类的疾病，并有助于培养人类的疾病，并有助于培训人类的疾病，并有助于培养人类的疾病。影响全球数百万人的问题。